Viewing nowTelmisartan 40 mg Tablet
Telmisartan 40mg
Tablet · Prescription medication
Unimed Pharmaceuticals Co., Ltd.

MFDS item code 201804271 · Approved 2018.10.29 · Insurance code 649507790
Treatment of essential hypertension and prevention of cardiovascular diseases (including myocardial infarction and stroke)
This medication helps to control blood pressure in patients with essential hypertension, promoting overall health. It is also effective in reducing the risk of heart attack, stroke, and mortality from cardiovascular diseases in patients over 55 who are at high risk of cardiovascular disease or who cannot use ACE inhibitors. It is particularly useful for high-risk diabetes patients with a history of coronary artery disease, peripheral artery disease, stroke, transient ischemic attacks, or evidence of end-organ damage. By lowering cardiovascular disease risk and stabilizing blood pressure, it improves the overall cardiovascular health of patients.
1. Essential hypertension Adults: Telmisartan should be administered orally with water at a dose of 40 mg once daily, and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. This drug has an additional blood pressure-lowering effect when coadministered with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that this drug be administered orally with water at a dose of 80 mg once daily, and it may be taken with or without food. The effect of reducing the risk of cardiovascular morbidity and mortality at doses below 80 mg is unknown. When starting treatment with this drug to reduce cardiovascular risk, it is recommended that blood pressure be monitored, and appropriate adjustment of antihypertensive medication may be required. ○ Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.
This medication can cause serious harm and risk of death to the fetus and newborn during pregnancy; therefore, treatment should be discontinued immediately if pregnancy is confirmed. It should not be administered to pregnant women, women of childbearing potential, patients with severe liver disease, or patients with certain hereditary diseases. Elderly patients, patients with hyperkalemia, and patients with mild to moderate liver dysfunction should use this medication with caution as there is a risk of rapidly dropping blood pressure. Blood pressure, kidney function, and serum potassium levels should be monitored regularly during treatment to ensure no abnormality. Serious side effects such as angioedema, liver dysfunction, renal failure, shock, and syncope may occur, and the physician should be consulted immediately if symptoms arise. Caution is needed when taken with other antihypertensive medications, as the blood pressure-lowering effect may be increased. The risk of hyperkalemia and worsening kidney function is particularly high when used in combination with other RAAS agents or potassium-sparing diuretics. It is advisable to discontinue this medication 24 hours before surgery, and caution should be exercised during activities such as driving or operating machinery due to the possibility of dizziness or fainting. Safety and effectiveness in pediatric patients have not been established, thus it is not recommended. Overdose may result in hypotension, dizziness, and acute renal failure; immediate medical attention should be sought in such cases. Store in a place out of reach of children and avoid moisture; it is best to open the package just before taking the dose.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. Storage temperature should be maintained between 1°C and 30°C to preserve the drug's effectiveness and safety.
White oblong tablet
30 tablets (10 tablets/Alu-Alu×3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowTelmisartan 40mg
Tablet · Prescription medication
Unimed Pharmaceuticals Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Sam-il Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Genewon Science Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.